tert-Butyl 3-hydroxy-3-methylpiperidine-1-carboxylate, 95.0%, 1g

Diethyl Acetylenedicarboxylate>96.0%(GC)25mL

1-(4-AMINO-1-METHYL-1H-PYRAZOL-3-YL)ETHANONE, 95.0%, 1g

3',3'',5',5''-Tetraiodophenolphthalein, 95.0%, 250mg

1-(1,4-diazepan-1-yl)-2-ethylhexan-1-one, 95.0%, 1g

3-(Fluorosulfonyl)-1,2-dimethyl-1H-imidazol-3-ium trifluoromethanesulfonate, 100g

(2-Oxo-2,3-dihydrobenzo[d]oxazol-6-yl)boronic acid, 95.0%, 5g

1,2-Bis(diphenylphosphino)ethane, 95.00%, 10g

3-Hydroxy-5-methylpicolinic acid, 98%, 1g

Monomethacryloxypropylterminated polydimethylsiloxane - asymmetric cSt 150-200 inhibited with BHT, 100g

4-(2-Fluorophenyl)piperidine hydrochloride, 95.0%, 500mg

N-(benzo[d]thiazol-2-yl)-1,2,3,4-tetrahydroisoquinoline-8-carboxamide dihydrochloride, 97%, 1g

2-(Cyclohexylamino)acetic acid hydrochloride, 98+%, 100mg